{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:12:55Z","timestamp":1785150775518,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1418,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"SRLF voucher","award":["TC00845191"],"award-info":[{"award-number":["TC00845191"]}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1186\/s13613-022-01026-4","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T03:10:53Z","timestamp":1655521853000},"page":"55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database"],"prefix":"10.1016","volume":"12","author":[{"given":"Alexander","family":"Balcerac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe-Elie","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-196X","authenticated-orcid":false,"given":"Nicolas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-022-01026-4_bb0010","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1097\/CCM.0000000000003278","article-title":"Features of adult hyperammonemia not due to liver failure in the intensive care unit","volume":"46","author":"Sakusic","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-022-01026-4_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1258\/acb.2011.011206","article-title":"Severe hyperammonaemia in adults not explained by liver disease","volume":"49","author":"Walker","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"10.1186\/s13613-022-01026-4_bb0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00415-010-5850-7","article-title":"A urinary cause of coma","volume":"258","author":"Weiss","year":"2011","journal-title":"J Neurol"},{"key":"10.1186\/s13613-022-01026-4_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jhep.2017.09.009","article-title":"Peak hyperammonemia and atypical acute liver failure: the eruption of an urea cycle disorder during hyperemesis gravidarum","volume":"68","author":"Weiss","year":"2018","journal-title":"J Hepatol"},{"key":"10.1186\/s13613-022-01026-4_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcrc.2020.02.003","article-title":"Ureaplasma parvum causes hyperammonemia presenting as refractory status epilepticus after kidney transplant","volume":"57","author":"Legouy","year":"2020","journal-title":"J Crit Care"},{"issue":"1","key":"10.1186\/s13613-022-01026-4_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14740\/jh322e","article-title":"Multiple myeloma induced hyperammonemic encephalopathy","volume":"6","author":"Murtaza","year":"2017","journal-title":"J Hematol"},{"key":"10.1186\/s13613-022-01026-4_bb0040","doi-asserted-by":"crossref","unstructured":"Salcedo JD, Goldstein JS, Quinonez JM, Mosetti MA (2019) Nonfatal hyperammonemic encephalopathy as a late complication of roux-en-y gastric bypass. In: case rep. gastrointest. Med. https:\/\/www.hindawi.com\/journals\/crigm\/2019\/9031087\/. Accessed 26 Jan 2021","DOI":"10.1155\/2019\/9031087"},{"key":"10.1186\/s13613-022-01026-4_bb0045","doi-asserted-by":"crossref","first-page":"284re3","DOI":"10.1126\/scitranslmed.aaa8419","article-title":"Disseminated ureaplasma infection as a cause of fatal hyperammonemia in humans","volume":"7","author":"Bharat","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1186\/s13613-022-01026-4_bb0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archinternmed.2009.549","article-title":"Iatrogenic hyperammonemia after anorexia","volume":"170","author":"Welsh","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1186\/s13613-022-01026-4_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jclinane.2014.09.008","article-title":"Fatal hyperammonemia after repeat renal transplantation","volume":"27","author":"Kiberenge","year":"2015","journal-title":"J Clin Anesth"},{"key":"10.1186\/s13613-022-01026-4_bb0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.06-2940","article-title":"Hyperammonemia in the ICU","volume":"132","author":"Clay","year":"2007","journal-title":"Chest"},{"key":"10.1186\/s13613-022-01026-4_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcrc.2019.12.005","article-title":"Characteristics and outcomes of critically ill patients with severe hyperammonemia","volume":"56","author":"Jacoby","year":"2020","journal-title":"J Crit Care"},{"key":"10.1186\/s13613-022-01026-4_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/fcp.12340","article-title":"Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study","volume":"32","author":"Weiss","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1186\/s13613-022-01026-4_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.9740\/mhc.2018.03.073","article-title":"Valproic acid\u2013induced hyperammonemia: Incidence, clinical significance, and treatment management","volume":"8","author":"Baddour","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1186\/s13613-022-01026-4_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0028-1102912","article-title":"Confusion, a rather serious adverse drug reaction with valproic acid: a review of the french pharmacovigilance database","volume":"42","author":"Bondon-Guitton","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1186\/s13613-022-01026-4_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1078155214551590","article-title":"Hyperammonemia secondary to asparaginase: a case series","volume":"22","author":"Nussbaum","year":"2016","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"10.1186\/s13613-022-01026-4_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejca.2020.01.019","article-title":"(2020) 5-fluorouracil-induced hyperammonaemic encephalopathy: a french national survey","volume":"129","author":"Boil\u00e8ve","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1186\/s13613-022-01026-4_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4174\/astr.2016.90.3.179","article-title":"Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy","volume":"90","author":"Yi","year":"2016","journal-title":"Ann Surg Treat Res"},{"key":"10.1186\/s13613-022-01026-4_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/009286150804200501","article-title":"VigiBase, the WHO global ICSR database system: basic facts","volume":"42","author":"Lindquist","year":"2008","journal-title":"Drug Inf J"},{"key":"10.1186\/s13613-022-01026-4_bb0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0167-9473(99)00114-0","article-title":"Bayesian neural networks with confidence estimations applied to data mining","volume":"34","author":"Orre","year":"2000","journal-title":"Comput Stat Data Anal"},{"key":"10.1186\/s13613-022-01026-4_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0962280211403604","article-title":"Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery","volume":"22","author":"Nor\u00e9n","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"10.1186\/s13613-022-01026-4_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1186\/s13613-022-01026-4_bb0120","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1186\/s13613-022-01026-4_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the french method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapies"},{"key":"10.1186\/s13613-022-01026-4_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2017.08.010","article-title":"Clinical pharmacology of anti-angiogenic drugs in oncology","volume":"119","author":"Gougis","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1186\/s13613-022-01026-4_bb0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9343(88)80239-0","article-title":"Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases","volume":"85","author":"Mitchell","year":"1988","journal-title":"Am J Med"},{"key":"10.1186\/s13613-022-01026-4_bb0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000205049","article-title":"Hyperammonemia in multiple myeloma","volume":"84","author":"Matsuzaki","year":"1990","journal-title":"Acta Haematol"},{"key":"10.1186\/s13613-022-01026-4_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/802121","article-title":"Valproic acid-induced hyperammonemia in the elderly: a review of the literature","volume":"2009","author":"Mittal","year":"2009","journal-title":"Case Rep Med"},{"key":"10.1186\/s13613-022-01026-4_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13613-022-00984-z","article-title":"L-carnitine does not improve valproic acid poisoning management: a cohort study with toxicokinetics and concentration\/effect relationships","volume":"12","author":"Nguyen","year":"2022","journal-title":"Ann Intensive Care"},{"key":"10.1186\/s13613-022-01026-4_bb0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","article-title":"Uses of pharmacovigilance databases: an overview","volume":"75","author":"Bihan","year":"2020","journal-title":"Therapie"},{"key":"10.1186\/s13613-022-01026-4_bb0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ando.2020.02.008","article-title":"androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes","volume":"82","author":"Salem","year":"2021","journal-title":"Ann Endocrinol"},{"key":"10.1186\/s13613-022-01026-4_bb0165","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/CIRCULATIONAHA.120.049210","article-title":"Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal src kinase","volume":"142","author":"Xiao","year":"2020","journal-title":"Circulation"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01026-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-022-01026-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01026-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:43:54Z","timestamp":1776671034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025006235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2110582025006235"],"URL":"https:\/\/doi.org\/10.1186\/s13613-022-01026-4","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-022-01026-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s) 2022. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"55"}}